Commonwealth Equity Services, LLC Kazia Therapeutics LTD Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 30,500 shares of KZIA stock, worth $71,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,500Holding current value
$71,370% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KZIA
# of Institutions
21Shares Held
2.13MCall Options Held
93.2KPut Options Held
0-
Mai Capital Management1.36MShares$3.19 Million0.01% of portfolio
-
Ubs Group Ag249KShares$583,7170.0% of portfolio
-
Morgan Stanley New York, NY220KShares$515,4100.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il60.5KShares$141,5130.0% of portfolio
-
Jane Street Group, LLC New York, NY46.1KShares$107,8970.0% of portfolio
About KAZIA THERAPEUTICS LTD
- Ticker KZIA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,111,300
- Market Cap $35.4M
- Description
- Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...